A Registry of Patients With Moderate to Severe Plaque Psoriasis
NCT02786186
·
clinicaltrials.gov ↗
COMPLETED
Status
2376
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Secikinumab
Sponsor
Novartis Pharmaceuticals